HOLLY CHANDLER: Open Payments
NPI 1447431226 · HILLSBORO, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$857 in 28 payments from 11 companies in 2025. Trend: 2023 $961 · 2024 $921 · 2025 $857
Food & beverage: $857
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $249 |
| UCB, Inc. | 3 | $161 |
| Lilly USA, LLC | 3 | $151 |
| LEO Pharma Inc. | 3 | $80 |
| ABBVIE INC. | 2 | $63 |
| Arcutis Biotherapeutics, Inc. | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| Galderma Laboratories, L.P. | 1 | $27 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
Products named: TREMFYA, Bimzelx, EBGLYSS, ANZUPGO, SKYRIZI, Zoryve, TALTZ, DUPIXENT.
Industry payments across OR — which companies pay providers there.
